Azithromycin in one week quadruple therapy for H pylori eradication in Iran

Table 1 Clinical and demographic data of patients in the treatment groups

Data	B-OAM-2 wk regimen n (%)	B-OAzM-1 wk regimen n (%)	P value¹
ITT analysis	71	58
Age: yr, Mean (SD)	48.3 (7.4)	46.7 (5.4)	0.17
Male	45 (63.3)	33 (56.8)	0.45
NSAID users	21 (29.5)	15 (25.8)	0.63
Cigarette smokers	11 (15.4)	8 (13.7)	0.78
Abdominal pain	47 (66.1)	31 (53.4)	0.14
Heartburn	14 (19.7)	18 (31)	0.13
Dyspepsia	57 (80.2)	40 (68.9)	0.13
PU	37 (52.1)	25 (43.1)	0.3
Non-ulcer dyspepsia	34 (47.8)	33 (56.8)	0.3
Loss to follow up	2	1
Poor compliance	3	2
Drop-outs	5	3
PP analysis	66	55

¹t; for means and χ² for proportions, ITT; intention to treat, PP; per protocol.